IRadimed Corporation IRMD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 24.68% | -10.31% | -9.69% | 15.51% | -3.41% |
| Total Depreciation and Amortization | 0.49% | -9.89% | 19.52% | -0.60% | 84.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.33% | 8.97% | -80.25% | 279.53% | -10.08% |
| Change in Net Operating Assets | -95.06% | -124.31% | 135.84% | -1,870.22% | -74.43% |
| Cash from Operations | 17.79% | -28.35% | 39.97% | -15.22% | -9.82% |
| Capital Expenditure | 29.73% | 54.09% | -36.98% | 74.15% | 56.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 68.22% | -290.91% | 45.99% | 3.02% | 32.98% |
| Cash from Investing | 52.14% | 5.54% | -12.63% | 67.06% | 55.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 91.88% | -368.00% | 97.84% | -7,630.67% | 68.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.04% | -0.04% | 70.12% | -295.48% | -0.09% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.67% | -7.10% | 76.03% | -395.82% | 2.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 200.00% |
| Net Change in Cash | 55.51% | -48.11% | 197.16% | -252.05% | 32.46% |